Mid-Size Pharmaceutical Market to Reach $100.05 Billion by 2028
Saturday, August 13, 2022
DUBLIN, Aug. 5, 2022 /PRNewswire/ -- The "Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Drug Development Type, Formulation, and Therapy Class" report has been added to ResearchAndMarkets.com's offering.
The mid-size pharmaceutical market is expected to grow from US$ 6,51,349.9 million in 2021 to US$ 10,00,584.3 million by 2028.
The increasing prevalence of chronic diseases and the rising number of products launches & approvals drive the market growth. However, cutthroat competition among market players hampers the mid-size pharmaceutical market growth.
Revenue, therapy area, R&D expenditure, and reach are among the critical segments of the global pharmaceutical industry. Mid-size pharmaceutical is among the three categories of the pharmaceutical industry. It emphasizes the development of generic drugs and the development of rare disease therapies.
The mid-sized pharmaceutical companies have their revenue in the range of US$ 1 billion to US$ 10 billion. The increasing prevalence of chronic diseases, rapidly rising elderly population, and the surging number of products launches & approvals is expected to aid the mid-size pharmaceutical market growth.
The aging population and changing social behavior contribute to the steady increase in common and costly long-term health problems. With the accelerating urbanization, people are adopting a sedentary lifestyle, which boosts the rates of obesity and cases of illnesses, such as diabetes.
Based on type, the mid-size pharmaceutical market is segmented into prescription and over-the-counter. In 2021, the over-the-counter segment held a larger market share. Furthermore, it is expected to register a higher CAGR of 6.7% during the forecast period.
Based on drug development type, the mid-size pharmaceutical market is segmented into in-house and outsource. In 2021, the outsource segment held a larger share of the market. It is expected to register a higher CAGR of 6.7% during 2021-2028.
Based on formulation, the mid-size pharmaceutical market is segmented into tablets & capsules, injectables, sprays, and other formulations. In 2021, the tablets & capsules segment held the largest share of the market. It is expected to register the highest CAGR of 7.1% during 2021-2028.
Based on therapy area, the mid-size pharmaceutical market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. In 2021, the diabetes segment held the largest share of the market. On the other hand, the cancer segment is expected to register the highest CAGR of 7.0% during 2021-2028.
-- Increasing Prevalence of Chronic Disorders
-- Increasing Product Approval and Launches
-- Cutthroat Competition among Market Players
-- Rising Number of Healthcare Start-ups
-- Greater Focus on R&D
Key Topics Covered:
2. Mid-Size Pharmaceutical - Key Takeaways
3. Research Methodology
4. Global Mid-Size Pharmaceutical - Market Landscape
5. Mid-Size Pharmaceutical Market - Key Market Dynamics
6. Mid-Size Pharmaceutical Market - Global Analysis
7. Global Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028 - by Type
8. Mid-Size Pharmaceutical Market Analysis - By Drug Development Type
9. Mid-Size Pharmaceutical Market - By Formulation
10. Mid-Size Pharmaceutical Market - By Therapy Class
11. Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 - Geographical Analysis
12. Impact Of COVID-19 Pandemic on Mid-Size Pharmaceutical Market
13. Mid-Size Pharmaceutical Market - Industry Landscape
14. Company Profiles
-- DAIICHI SANKYO COMPANY LIMITED
-- Eisai Co., Ltd.
-- Bausch Health Companies Inc.
-- Regeneron Pharmaceuticals, Inc
-- Sun Pharmaceutical Industries Ltd
-- Alexion Pharmaceuticals, Inc.
-- Endo Pharmaceuticals Inc.
-- Les Laboratories Servier
-- UCB S.A.
For more information about this report visit https://www.researchandmarkets.com/r/dfrm8o
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/mid-size-pharmaceutical-market-to-reach-100-05-billion-by-2028--301600678.html
SOURCE Research and Markets
||Flavors and Fragrances Market Report by Technavio predicts USD 10.44 Bn growth -- Driven by an increasing number of new product launches | Sep 27, 2022
||Hexamethylenediamine Market 2026, Increasing Demand For Recycled Plastics to Boost Growth - Technavio | Sep 27, 2022
||Survivor Pens a Thought-Provoking Prayer Book For Abuse Victims and Their Devoted Support Teams | Sep 27, 2022
||Hold On A Minute; God Can Do Anything He Wants To, Right? | Sep 27, 2022
||Instead of Seeing Prophecy as "Mysterious", Consider That God Wanted You to Know! | Sep 27, 2022
||Eye-Opening Answers to Questions About Life, Faith and the Bible | Sep 27, 2022
||What Do You Do When You Believe God Has Opened All The Doors, Then They Slam In Your Face? | Sep 27, 2022
||Volume 1 of Fictional Series Presents Fun, Relatable and Relevant Stories | Sep 27, 2022
||Let the Great Minds and Hearts of the Past Guide You in the Present | Sep 27, 2022
||Security Services Market In India 2026, Economic Development Of The Nation to Boost Market Growth - Technavio | Sep 27, 2022